Apimeds Pharmaceuticals US Overview
Apimeds Pharmaceuticals US Discounted Cash Flow
DCF Analysis for APUS.
Get informed when a big investor buys or sells
+ FollowFair Value
$-0.56
Current Fair Value
$-0.56
↓ 142.3% Downside
Overvalued by 142.3% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison